Showing 201 - 220 results of 3,943 for search '"mutation"', query time: 0.07s Refine Results
  1. 201
  2. 202
  3. 203

    KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature by Sarah Bouri, Jean-Christophe Noël, Xavier Catteau, Walid Al Hajj Obeid, Ilyas Svistakov, Thierry Roumeguère, Nicky D’Haene, Sandrine Rorive

    Published 2020-01-01
    “…The diagnosis of a serous borderline tumor of the testis was proposed. Mutation testing using next-generation sequencing showed a Q61K KRAS gene mutation. …”
    Get full text
    Article
  4. 204
  5. 205

    A Case Series on Cardiac and Skeletal Involvement in Two Families with PRKAG2 Mutations by Anita Sri, Piers Daubeney, Sanjay Prasad, John Baksi, Maria Kinali, Inga Voges

    Published 2019-01-01
    “…This case report demonstrates that the PRKAG2 mutation presents with various phenotypes already in pediatric patients. …”
    Get full text
    Article
  6. 206
  7. 207

    The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer by Jun Jiang, Yan Zhan, Jun Li

    Published 2022-01-01
    “…We then identified differentially expressed genes (DEGs) and differentially mutated genes (DMGs) according to the high-stromal score cohort and low-stromal score cohort. …”
    Get full text
    Article
  8. 208

    De Novo Heterozygous Mutation in FGFR2 Causing Type II Pfeiffer Syndrome by Rafat Mosalli, Alfia Fatma, Mohammed A. Almatrafi, Mayada Mazroua, Bosco Paes

    Published 2022-01-01
    “…Pfeiffer syndrome (PS) is an autosomal dominant disorder with three subtypes stemming from heterozygous mutations in the fibroblast growth factors FGFR1 and FGFR2. …”
    Get full text
    Article
  9. 209

    Variable Presentation of the CYBB Mutation in One Family, Approach to Management, and a Review of the Literature by Tatyana Gavrilova, Ari Zelig, Diana H. Lee

    Published 2020-01-01
    “…This article describes a family with the CYBB mutation, its heterogenous presentation, and reviews the literature discussing disease management.…”
    Get full text
    Article
  10. 210
  11. 211
  12. 212

    Simulating the Emergence and Survival of Mutations Using a Self Regulating Multitype Branching Processes by Charles J. Mode, Towfique Raj, Candace K. Sleeman

    Published 2011-01-01
    “…It is difficult for an experimenter to study the emergence and survival of mutations, because mutations are rare events so that large experimental population must be maintained to ensure a reasonable chance that a mutation will be observed. …”
    Get full text
    Article
  13. 213

    Molecular identification of pfcytb, pfdhfr, and pvmrp1 mutations in imported malaria cases in Chile by Alan Oyarce, Lizbeth Huaccha, Esteban M. Cordero, Bárbara Parra, Jorge Fernández, Mario E. Soto-Marchant, Natalia T. Santis-Alay, María Isabel Jercic

    Published 2025-01-01
    “…All the genes analyzed had at least one mutation. In the pfdhfr gene, three mutations were observed (S108N/N51I/C59R). …”
    Get full text
    Article
  14. 214
  15. 215

    LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient by Ivanka Dimova, Ivo Kremensky

    Published 2018-01-01
    “…Here we present a patient diagnosed postmortem as having early-onset LAMA2-related muscular dystrophy as a result of mutations in LAMA2, identified by Sanger sequencing in his parents: a novel nonsense mutation c.4452T>A in exon 31, identified in the mother, and a known pathogenic nonsense mutation c.2901C>A in exon 21, detected in the father. …”
    Get full text
    Article
  16. 216

    Cost-effectiveness of lazertinib as first-line treatment in patients with -mutated advanced lung cancer by Li-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen, Szu-Chun Yang

    Published 2025-01-01
    “…Background: Lazertinib demonstrates efficacy similar to that of osimertinib in the first-line treatment of epidermal growth factor receptor ( EGFR )-mutated advanced lung cancer. However, its cost-effectiveness has not yet been evaluated. …”
    Get full text
    Article
  17. 217

    Zellweger syndrome; identification of mutations in PEX19 and PEX26 gene in Saudi families by Abdulfatah M. Alayoubi, Ambreen Ijaz, Abdul Wali, Jamil A. Hashmi, Azizah Alharbi, Sulman Basit

    Published 2025-12-01
    “…Both variants were segregating in an autosomal recessive manner in the respective families.Conclusion The present study has added a novel nonsense mutation to the mutation spectrum of PEX19, which is the second null mutation identified to date. …”
    Get full text
    Article
  18. 218

    Nonfamilial Juvenile Polyposis Syndrome with Exon 5 Novel Mutation in SMAD 4 Gene by Amna Ahmed, Badr Alsaleem

    Published 2017-01-01
    “…JPS is most frequently caused by mutations in the SMAD4 or BMPR1A genes. Herein, we report a child with juvenile polyposis syndrome (JPS) with a novel mutation in the SMAD4 gene. …”
    Get full text
    Article
  19. 219
  20. 220

    Trio-based whole-exome sequencing reveals mutations in early-onset high myopia by Ding Chen, Xiu-Feng Huang, Juan Huang, Yi-Ming Guo, Junhan Wei, Lu Ye, Yi-Xin Cai, Jiejing Bi, Fen-Fen Li

    Published 2024-05-01
    “…Pathogenic mutations were found in syndromic myopia genes, notably encompassing VPS13B, TRPM1, RPGR, NYX and RP2. …”
    Get full text
    Article